Drug
Alglucosidase Alfa
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Poor Venous Access | 32 | 27.3 | 27.6 | signal |
| 2 | Device Related Infection | 29 | 16.5 | 16.7 | signal |
| 3 | Device Occlusion | 24 | 15.1 | 15.3 | signal |
| 4 | Infusion Related Reaction | 83 | 11.0 | 11.4 | signal |
| 5 | Inappropriate Schedule Of Product Administration | 204 | 10.1 | 11.0 | signal |
| 6 | Aspiration | 12 | 9.7 | 9.8 | signal |
| 7 | Respiratory Distress | 28 | 8.9 | 9.0 | signal |
| 8 | Blood Creatine Phosphokinase Increased | 27 | 8.1 | 8.2 | signal |
| 9 | Hypotonia | 9 | 7.9 | 7.9 | signal |
| 10 | Oxygen Saturation Decreased | 47 | 7.4 | 7.5 | signal |
| 11 | Body Temperature Increased | 17 | 7.3 | 7.3 | signal |
| 12 | Respiratory Tract Infection | 21 | 7.1 | 7.1 | signal |
| 13 | Infusion Site Pain | 10 | 6.9 | 6.9 | signal |
| 14 | Product Preparation Error | 16 | 6.8 | 6.8 | signal |
| 15 | Gastroenteritis Viral | 13 | 6.3 | 6.3 | signal |
| 16 | Respiratory Disorder | 21 | 6.1 | 6.2 | signal |
| 17 | Pneumothorax | 11 | 6.1 | 6.1 | signal |
| 18 | Hypothermia | 7 | 6.1 | 6.1 | signal |
| 19 | Eyelid Ptosis | 7 | 6.0 | 6.1 | signal |
| 20 | Tachypnoea | 9 | 5.8 | 5.8 | signal |
| 21 | Pharyngitis Streptococcal | 7 | 5.7 | 5.7 | signal |
| 22 | Sars-cov-2 Test Positive | 8 | 5.3 | 5.3 | signal |
| 23 | Muscular Weakness | 67 | 5.2 | 5.3 | signal |
| 24 | Secretion Discharge | 7 | 5.0 | 5.0 | signal |
| 25 | Urticaria | 87 | 4.6 | 4.7 | signal |
| 26 | Femur Fracture | 16 | 4.5 | 4.5 | signal |
| 27 | Cyanosis | 8 | 4.5 | 4.5 | signal |
| 28 | Brain Injury | 5 | 4.4 | 4.4 | signal |
| 29 | Illness | 49 | 4.3 | 4.3 | signal |
| 30 | Heart Rate Increased | 45 | 4.0 | 4.0 | signal |
| 31 | Complication Associated With Device | 6 | 4.0 | 4.0 | signal |
| 32 | Ear Infection | 12 | 4.0 | 4.0 | signal |
| 33 | Incorrect Product Administration Duration | 9 | 3.9 | 3.9 | signal |
| 34 | Pallor | 11 | 3.5 | 3.5 | signal |
| 35 | Unevaluable Event | 29 | 3.4 | 3.4 | signal |
| 36 | Therapeutic Response Decreased | 23 | 3.3 | 3.4 | signal |
| 37 | Throat Tightness | 10 | 3.2 | 3.3 | signal |
| 38 | Exposure During Pregnancy | 23 | 3.2 | 3.3 | signal |
| 39 | Product Storage Error | 32 | 3.2 | 3.3 | signal |
| 40 | Hospitalisation | 55 | 3.2 | 3.2 | signal |
| 41 | Hip Fracture | 11 | 3.0 | 3.0 | signal |
| 42 | Disease Progression | 40 | 3.0 | 3.0 | signal |
| 43 | Flushing | 34 | 2.9 | 2.9 | signal |
| 44 | Respiratory Arrest | 9 | 2.8 | 2.8 | signal |
| 45 | Tooth Extraction | 4 | 2.8 | 2.8 | no signal |
| 46 | Ovarian Cyst | 3 | 2.6 | 2.6 | no signal |
| 47 | Pulmonary Thrombosis | 3 | 2.4 | 2.4 | no signal |
| 48 | Product Dose Omission | 17 | 2.3 | 2.3 | signal |
| 49 | Intercepted Product Preparation Error | 3 | 2.2 | 2.2 | no signal |
| 50 | Incorrect Product Storage | 3 | 2.0 | 2.0 | no signal |
| 51 | Incorrect Dose Administered | 50 | 1.9 | 2.0 | no signal |
| 52 | Device Issue | 17 | 1.7 | 1.7 | no signal |
| 53 | Abortion Spontaneous | 7 | 1.5 | 1.5 | no signal |
| 54 | Wrong Technique In Drug Usage Process | 4 | 1.0 | 1.0 | no signal |
| 55 | Myelosuppression | 3 | 0.8 | 0.8 | no signal |